Boston Scientific | BSX

Stock Price
74.94
Daily Change
-0.21 -0.27%
Monthly
4.31%
Yearly
48.43%
Q2 Forecast
73.73
Peers Price Chg Day Year Date
Abbott 100.74 -1.11 -1.09% -0.95% May/29
AtriCure 21.61 -1.06 -4.68% -52.72% May/29
Avanos Medical 19.35 -0.85 -4.21% -19.21% May/29
Baxter International 33.15 -0.68 -2.01% -17.80% May/29
Becton, Dickinson and Co. 225.00 -1.99 -0.88% -5.62% May/29
Boston Scientific 74.94 -0.21 -0.27% 48.43% May/29
CONMED 74.24 -0.28 -0.38% -37.34% May/29
Cooper Companies 91.12 -0.47 -0.51% -1.01% May/29
Danaher 255.93 -2.79 -1.08% 12.66% May/29
Dexcom 127.67 0.52 0.41% 12.43% May/29
Edwards Lifesciences 87.02 0.04 0.05% 6.88% May/29
Globus Medical 65.27 -0.22 -0.34% 24.06% May/29
Hologic 72.34 -0.96 -1.30% -8.03% May/29
Integra LifeSciences 29.60 0.73 2.53% -22.74% May/29
Illumina 101.75 -3.17 -3.02% -47.69% May/29
Intuitive Surgical 399.08 -3.16 -0.79% 29.96% May/29
J&J 144.27 -0.14 -0.10% -6.54% May/29
Masimo 126.93 -0.25 -0.20% -18.70% May/29
Medtronic 80.87 -0.40 -0.49% -1.98% May/29
Merit Medical Systems 80.43 -1.07 -1.31% -1.24% May/29
Insulet 172.32 -5.36 -3.02% -36.78% May/29
Stryker 341.14 2.37 0.70% 25.65% May/29
Teleflex 202.65 -1.51 -0.74% -12.67% May/29
Tandem Diabetes Care 51.75 -1.15 -2.17% 94.62% May/29
Zimmer Biomet Holdings 116.56 0.20 0.17% -7.81% May/29

Indexes Price Day Year Date
US500 5255 -39.10 -0.74% 25.72% May/30

Boston Scientific traded at $74.94 this Wednesday May 29th, decreasing $0.21 or 0.27 percent since the previous trading session. Looking back, over the last four weeks, Boston Scientific lost 4.31 percent. Over the last 12 months, its price rose by 48.43 percent. Looking ahead, we forecast Boston Scientific to be priced at 73.73 by the end of this quarter and at 71.61 in one year, according to Trading Economics global macro models projections and analysts expectations.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.